Morgan Stanley’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,000
| Closed | -$2.77K | – | 8035 |
|
|
2023
Q3 | $2.77K | Sell |
32,000
-957,280
| -97% | -$82.9K | ﹤0.01% | 7057 |
|
|
2023
Q2 | $554K | Sell |
989,280
-68,278
| -6% | -$38.2K | ﹤0.01% | 5155 |
|
|
2023
Q1 | $1.21M | Sell |
1,057,558
-39,075
| -4% | -$44.5K | ﹤0.01% | 4747 |
|
|
2022
Q4 | $1.23M | Sell |
1,096,633
-76,571
| -7% | -$85.8K | ﹤0.01% | 4746 |
|
|
2022
Q3 | $2.46M | Sell |
1,173,204
-47,549
| -4% | -$99.9K | ﹤0.01% | 4282 |
|
|
2022
Q2 | $1.66M | Sell |
1,220,753
-53,164
| -4% | -$72.3K | ﹤0.01% | 4673 |
|
|
2022
Q1 | $2.15M | Sell |
1,273,917
-92,111
| -7% | -$156K | ﹤0.01% | 4468 |
|
|
2021
Q4 | $1.48M | Sell |
1,366,028
-56,747
| -4% | -$61.3K | ﹤0.01% | 4802 |
|
|
2021
Q3 | $4.2M | Sell |
1,422,775
-245,876
| -15% | -$725K | ﹤0.01% | 3921 |
|
|
2021
Q2 | $5.02M | Sell |
1,668,651
-262,130
| -14% | -$789K | ﹤0.01% | 3773 |
|
|
2021
Q1 | $6.3M | Buy |
1,930,781
+691,486
| +56% | +$2.25M | ﹤0.01% | 3168 |
|
|
2020
Q4 | $5.11M | Buy |
1,239,295
+977,151
| +373% | +$4.03M | ﹤0.01% | 3235 |
|
|
2020
Q3 | $1.42M | Buy |
262,144
+243,746
| +1,325% | +$1.32M | ﹤0.01% | 3951 |
|
|
2020
Q2 | $124K | Buy |
18,398
+265
| +1% | +$1.79K | ﹤0.01% | 5300 |
|
|
2020
Q1 | $57K | Sell |
18,133
-73,262
| -80% | -$230K | ﹤0.01% | 5422 |
|
|
2019
Q4 | $639K | Buy |
91,395
+48,654
| +114% | +$340K | ﹤0.01% | 4788 |
|
|
2019
Q3 | $164K | Buy |
42,741
+11,446
| +37% | +$43.9K | ﹤0.01% | 5236 |
|
|
2019
Q2 | $119K | Sell |
31,295
-19,312
| -38% | -$73.4K | ﹤0.01% | 5245 |
|
|
2019
Q1 | $182K | Buy |
50,607
+26,796
| +113% | +$96.4K | ﹤0.01% | 5114 |
|
|
2018
Q4 | $185K | Buy |
+23,811
| New | +$185K | ﹤0.01% | 5313 |
|